Understanding how tau proteins cause neurodegenerative diseases.
Pathogenesis of Tauopathies
This study is looking at how tau proteins behave in diseases like Alzheimer's, hoping to find ways to stop the harmful spread of these proteins so that we can develop better treatments for patients.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pennsylvania NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-11060928 on NIH RePORTER |
What this research studies
This research investigates the role of tau proteins in various neurodegenerative diseases known as tauopathies. It aims to understand how different forms of tau can induce the aggregation of normal tau proteins, leading to disease progression. By exploring the interaction between tau and amyloid beta plaques, the study seeks to identify potential therapeutic targets that could inhibit the harmful transmission of tau aggregates. Patients may benefit from insights that could lead to more effective treatments for conditions like Alzheimer's disease.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals diagnosed with tauopathies, particularly those with Alzheimer's disease.
Not a fit: Patients with tauopathies not related to Alzheimer's disease or those with other unrelated neurodegenerative conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to targeted therapies that slow or halt the progression of tauopathies, improving patient outcomes.
How similar studies have performed: Previous research has shown promise in understanding tau pathology, indicating that this approach may lead to significant advancements in treatment.
Where this research is happening
Philadelphia, United States
- University of Pennsylvania — Philadelphia, United States (Active)
Researchers
- Principal investigator: Lee, Virginia M — University of Pennsylvania
- Study coordinator: Lee, Virginia M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.